Franco Locatelli
IRCSS Ospedale Pediatrico Bambino Gesù · Director Department of Hematology/Oncology and Cell and Gene Therapy · IRCCS Ospedale Pediatrico Bambino Gesù, Piazza Sant'Onofrio, 4, 00165 Rome, IT
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Franco Locatelli as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:23 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07297914 · Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALLBambino Gesù Hospital and Research Institute · recruiting · Acute Lymphoblastic Leukemia (ALL), Stem Cell Transplant, Graft -Versus-host-disease · principal investigator
- Ph1NCT06080191 · Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALLBambino Gesù Hospital and Research Institute · recruiting · B-cell Acute Lymphoblastic Leukemia · principal investigator
- Ph1/Ph2NCT06064903 · CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LLBambino Gesù Hospital and Research Institute · recruiting · T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma · principal investigator
- Ph1/Ph2NCT03605212 · Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and AdultsMenarini Group · terminated · Tumor Lysis Syndrome · study chair
- Ph2NCT03055247 · Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGDIRCCS San Raffaele · recruiting · Chronic Granulomatous Disease X-linked (X-CGD) · principal investigator
- Ph4NCT02670564 · ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)Swiss Pediatric Oncology Group · unknown · Acute Lymphoblastic Leukemia · study chair
- Ph1/Ph2NCT02504619 · Allogeneic SCT of CordIn™, in Patients With HemoglobinopathiesGamida Cell ltd · terminated · Sickle Cell Disease, Thalassemia · principal investigator
- Ph2/Ph3NCT01949129 · Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaemiaSt. Anna Kinderkrebsforschung · recruiting · Acute Lymphoblastic Leukaemia · study chair
- Ph2NCT01810926 · T&B Depletion Non MalignantFranco Locatelli · unknown · Graft Versus Host Disease · principal investigator
- Ph1/Ph2NCT01810120 · Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCTMariella Enoc · completed · Acute Lymphoblastic Leukemia, Leukemia Acute Myeloid - AML, Non-Hodgkin Lymphoma · principal investigator
- Ph2/Ph3NCT00469729 · Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative TherapyGamida Cell -Teva Joint Venture Ltd. · completed · Hematologic Malignancies, Acute Myeloid Leukemia, Lymphoid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in childhood acute lymphoblastic leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 11:23 UTC. The ranking covers the 200 most relevant of 46 PubMed records, and a shared surname and initials can bring in a namesake. All 46 on PubMed
- 625 citationsRCR 15.2
- Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.J Clin Oncol · 2016491 citationsRCR 15.2
- 349 citationsRCR 8.5
- 298 citationsRCR 16.5
- Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study.J Clin Oncol · 2021290 citationsRCR 19.0
- 224 citationsRCR 7.9
- Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.J Clin Oncol · 2005173 citationsRCR 3.5
- 149 citationsRCR 4.0
- 128 citationsRCR 3.2
- 124 citationsRCR 3.0